Nalaganje...
Development of Liposomal Ciprofloxacin to Treat Lung Infections
Except for management of Pseudomonas aeruginosa (PA) in cystic fibrosis, there are no approved inhaled antibiotic treatments for any other diseases or for infections from other pathogenic microorganisms such as tuberculosis, non-tuberculous mycobacteria, fungal infections or potential inhaled biowar...
Shranjeno v:
| izdano v: | Pharmaceutics |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4810082/ https://ncbi.nlm.nih.gov/pubmed/26938551 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics8010006 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|